<unk>  for<unk><unk>  by cell-based quantitative assays for  JAK2V617F mutation  is recommended among individuals with a positive family history for the disease (autosomal dominant inheritance) and in patients who present with<unk> , erythrocytosis, and monocytosis.
Essential thrombocytosis screening
Von Willebrand disease screening
Thrombophilia screening
Disseminated intravascular coagulation screening
Splenic vein thrombosis screening
Deep vein thrombosis screening
Diabetic foot screening
Fibromuscular dysplasia screening